Financial Position - As of September 30, 2025, Eledon Pharmaceuticals reported estimated cash, cash equivalents, and short-term investments of approximately $93.4 million[6] Clinical Trials - The company announced results from its Phase 2 BESTOW trial evaluating tegoprubart for the prevention of organ rejection in kidney transplant patients[9] - A conference call is scheduled for November 7, 2025, to discuss updated Phase 2 BESTOW clinical data[10]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO _____________ Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) (State or other juris ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33520 _______ ...

Financial Performance - Oil and natural gas sales for Q3 2025 were $112.7 million, with net income of $14.5 million, or $0.11 per diluted share, compared to $9.1 million, or $0.07 per diluted share in Q3 2024[5][8] - Adjusted EBITDAX for Q3 2025 totaled $78.6 million, up from $75.4 million in Q3 2024, while cash flow from operating activities was $77.8 million[6][8] - Net income for the nine months ended September 30, 2025, was $49,416,000, compared to $30,381,000 for the same period in 2024, reflecting a growth of 62.7%[33] - The company’s net income for Q3 2025 was $14.523 million, a 60.5% increase from $9.054 million in Q3 2024[44] - Adjusted Net Income for the nine months ended September 30, 2025, was $54,695,000, up from $50,946,000 in the same period of 2024, reflecting a 3.7% growth[50] - Earnings per diluted share for Q3 2025 was $0.11, up from $0.07 in Q3 2024, marking a 57.1% increase[50] - Adjusted Earnings Per Diluted Share for the nine months ended September 30, 2025, was $0.42, compared to $0.39 in 2024, reflecting a 7.7% growth[50] Production and Sales - Daily oil production volumes increased by 28% to 16,222 barrels per day, and natural gas production rose by 25% to 94,217 thousand cubic feet per day[7][8] - Oil and natural gas sales for the three months ended September 30, 2025, were $112,671,000, a 19.8% increase from $94,075,000 in the same period of 2024[31] - Oil sales amounted to $91.960 million in Q3 2025, up 7.4% from $85.503 million in Q3 2024[35] - Natural gas and related product sales surged to $20.711 million, a significant increase of 142.5% compared to $8.572 million in Q3 2024[35] - The company reported a total production of 2,937 MBoe in Q3 2025, an increase of 26.8% from 2,316 MBoe in Q3 2024[35] Expenses and Liabilities - Lease operating expenses were $23.6 million, or $8.03 per barrel of oil equivalent, compared to $13.0 million, or $5.62 per barrel of oil equivalent in the same period last year[10][8] - Operating expenses for Q3 2025 totaled $93.081 million, up from $69.060 million in Q3 2024, indicating a 34.8% increase[35] - Total current liabilities decreased to $76,963,000 as of September 30, 2025, down from $101,808,000 at December 31, 2024, a reduction of approximately 24.4%[29] - Long-term debt increased to $300,000,000 as of September 30, 2025, from $205,000,000 at December 31, 2024, representing a rise of 46.3%[29] Investments and Capital Expenditures - The company invested $64.0 million in development capital expenditures and $16.5 million in acquisition capital, closing 17 acquisitions in the Permian and Utica Basins[11][8] - Capital expenditures for oil and natural gas properties amounted to $233,135,000 for the nine months ended September 30, 2025, compared to $193,376,000 in 2024, indicating an increase of 20.6%[33] - The company has provided 2025 guidance for annual production between 31,000 and 33,000 barrels of oil equivalent per day, with total capital expenditures expected to be between $400 million and $420 million[17][8] Shareholder Returns - The company declared a quarterly dividend of $0.11 per share, payable on December 15, 2025[8][4] Other Financial Metrics - The gain on derivatives for the three months ended September 30, 2025, was $5,224,000, compared to $11,841,000 in the same period of 2024, a decrease of 55.8%[31] - The company reported a net cash provided by operating activities of $231,914,000 for the nine months ended September 30, 2025, compared to $207,536,000 in 2024, an increase of 11.7%[33] - The company’s net debt as of September 30, 2025, was $288.168 million, with a net debt to trailing twelve months Adjusted EBITDAX ratio of 0.9[46][47] - The total working capital changes for Q3 2025 resulted in a decrease of $4,663,000, compared to a decrease of $3,987,000 in Q3 2024[53] - The company incurred nonrecurring general and administrative expenses of $1,757,000 related to severance costs in the nine months ended September 30, 2025[50] - The tax impact on adjustments for the nine months ended September 30, 2025, was a negative $1,542,000, compared to a negative $6,143,000 in 2024[50]

Financial Performance - Q3 2025 revenues increased by 2.9% to $363.7 million compared to $353.6 million in Q3 2024[6] - Income from operations rose 197.0% to $28.4 million, significantly improving from a loss of $(29.3) million in Q3 2024[6] - Net loss decreased to $(3.6) million from $(48.6) million in Q3 2024, marking a 92.6% improvement[6] - Adjusted EBITDA for Q3 2025 was $124.1 million, slightly down by 0.5% from $124.7 million in Q3 2024[6] - Adjusted net income for the quarter was $71.5 million, a decrease of 0.8% compared to $72.1 million in Q3 2024[6] - Free cash flow increased by 35.0% to $108.2 million from $80.1 million in Q3 2024[6] - Total revenues for the three months ended September 30, 2025, were $363.711 million, an increase from $353.580 million in the same period of 2024, representing a growth of 3.2%[18] - Net income for the nine months ended September 30, 2025, was $46.984 million, compared to a net loss of $1.040 million in the same period of 2024[20] Cost Management - Operating costs and expenses for the three months ended September 30, 2025, totaled $335.283 million, a decrease from $382.884 million in the same period of 2024, reflecting a reduction of 12.4%[18] - The company incurred a goodwill impairment of $17.579 million for the three months ended September 30, 2025, compared to $85.273 million in the same period of 2024[18] - Share-based compensation for the three months ended September 30, 2025, amounted to $12,197 thousand, compared to $10,161 thousand in the same period of 2024[31] - Sales and marketing expenses decreased to $(133,762) from $(127,418) year-over-year, indicating a focus on cost management[39][42] - Research, development, and engineering costs were reduced to $(14,077) from $(15,255), reflecting efficiency improvements[39][42] - General, administrative, and other related costs decreased to $(38,733) from $(52,417), showcasing effective expense control measures[39][42] - Depreciation and amortization expenses were reported at $(26,124), down from $(51,351) in the prior year, indicating a reduction in asset-related costs[39][42] Guidance and Projections - The company reaffirmed its 2025 revenue guidance range of $1,442 million to $1,502 million[8] - Adjusted EBITDA guidance for 2025 is set between $505 million and $542 million[8] - Adjusted diluted EPS is projected to be between $6.64 and $7.28 for 2025[8] Cash Flow and Investments - Cash flows from operating activities for the nine months ended September 30, 2025, were $215.986 million, slightly down from $232.082 million in the same period of 2024[20] - Total cash and cash equivalents at the end of the period were $503.368 million, down from $386.122 million at the end of September 2024[20] - The company spent $85.888 million on property and equipment purchases in the nine months ended September 30, 2025, compared to $79.476 million in the same period of 2024[20] - Free cash flow for the year-to-date 2025 was $130,098, with net cash provided by operating activities totaling $215,986[50] Adjustments and Non-GAAP Measures - The adjusted effective tax rate is calculated based on the GAAP effective tax rate with adjustments for non-GAAP adjustments to net income[29] - For the three months ended September 30, 2025, the adjusted net income was $71,470, with an adjusted effective tax rate of approximately 25.2%[39] - Total non-GAAP adjustments for the quarter amounted to $24,015, indicating significant adjustments made to reconcile GAAP to non-GAAP financial measures[39][42] - For the nine months ended September 30, 2025, the adjusted net income was $172,042, with an adjusted effective tax rate of approximately 24.6%[44] - The total non-GAAP adjustments for the same period amounted to $69,066 in share-based compensation and $27,292 in transaction and integration charges[44] Investment and Credit Management - The company reported a provision for credit losses on investments of $17.566 million for the nine months ended September 30, 2025, compared to no provision in the same period of 2024[20] - The company reported a provision for credit losses on investments of $(17,566), reflecting a cautious approach to credit risk management[39][42]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-Q ____________________ (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 06-1500476 (I.R.S. Employer Identification No.) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCH ...

Earnings Performance - Alliant Energy reported GAAP EPS of $1.09 for Q3 2025, down from $1.15 in Q3 2024, while ongoing EPS was $1.12, also down from $1.15 year-over-year[1][5] - For the first nine months of 2025, EPS increased by 23.3% to $2.59 from $2.10 in the same period of 2024, with ongoing EPS rising 12.4% to $2.62 from $2.33[2][6] - Alliant Energy's consolidated GAAP EPS for Q3 2025 was $1.09, down from $1.15 in Q3 2024, while non-GAAP EPS remained at $1.12 compared to $1.15 in the previous year[33] - For the nine months ended September 30, 2025, Alliant Energy reported a consolidated GAAP income of $668 million, an increase from $540 million in the same period of 2024, with non-GAAP income rising to $676 million from $599 million[33] - The adjusted non-GAAP EPS for the nine months ended September 30, 2025, was $2.62, compared to $2.33 in 2024, reflecting a significant increase in operational performance[33] - Net income attributable to Alliant Energy common shareowners for Q3 2025 was $281 million, a decrease of 4.8% from $295 million in Q3 2024[37] Revenue and Expenses - The primary drivers for the Q3 results included higher revenue from authorized base rate increases, offset by increased operational and maintenance expenses[5][7] - Total revenues for Q3 2025 increased to $1,210 million, up 11.9% from $1,081 million in Q3 2024[37] - Operating income for the nine months ended September 30, 2025, rose to $828 million, a 24.5% increase compared to $665 million in the same period of 2024[37] - The income from IPL for Q3 2025 was $165 million, compared to $190 million in Q3 2024, while WPL's income increased to $123 million from $114 million[33] Guidance and Future Outlook - The company narrowed its 2025 ongoing EPS guidance to $3.17 - $3.23 per share, with 2026 guidance set at $3.36 - $3.46, representing a 6.6% increase over 2025[4][11] - The expected annual common stock dividend target for 2026 has been raised to $2.14 per share, a 5.4% increase from 2025[4][12] - The forecasted capital expenditures for 2026-2029 have been increased to $13.4 billion, a 17% rise to meet growing energy demand[3][6] - Alliant Energy's capital expenditures guidance for 2025-2029 was highlighted, indicating a focus on future growth and infrastructure development[25] Customer and Market Information - Alliant Energy serves approximately 1,010,000 electric and 430,000 natural gas customers, focusing on regulated electricity and natural gas services in the Midwest[21] - Total utility retail electric customers reached 1,006,524 as of September 30, 2025, an increase from 999,893 in the same period of 2024[43] - Utility electric sales for residential customers in Q3 2025 were 2,154,000 megawatt-hours, an increase of 4.0% from 2,071,000 megawatt-hours in Q3 2024[43] Financial Position - Cash and cash equivalents increased significantly to $503 million as of September 30, 2025, compared to $81 million at the end of 2024[39] - Total assets grew to $24,627 million as of September 30, 2025, up from $22,714 million at the end of 2024[39] - Long-term debt, net (excluding current portion) increased to $10,655 million as of September 30, 2025, compared to $8,677 million at the end of 2024[39] Challenges and Considerations - Alliant Energy is facing challenges related to inflation and higher interest rates, which may impact operational costs and capital expenditures[25] - The company reported a state income tax apportionment charge of $8 million for Q3 2025, which was not present in the previous year, affecting non-GAAP earnings[34] - The company emphasized the importance of achieving expected tax benefits for renewable generation projects, which are crucial for maintaining authorized rates of return[25] - The company is actively monitoring regulatory changes that could impact renewable tax credits and overall operational compliance[25] Dividend Information - The quarterly common dividend rate per share increased to $0.5075 in Q3 2025, up from $0.48 in Q3 2024[43] - Alliant Energy's ability to sustain its dividend payout ratio goal remains a priority, with ongoing assessments of market conditions and financial performance[31] Data Center Demand - Alliant Energy's contracted demand from data centers has reached 3 gigawatts, anticipating a 50% increase in peak load demand by 2030[3][6] - The company has secured four data center agreements and is positioned for further growth opportunities in energy demand[5][6]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-31977 COMMUNITY WEST BANCSHARES (Exact name of registrant as specified in its charter) California 77-0539125 (I.R.S. Employer ...

Table of Contents ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-34511 ______________________________________ FORTINET, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or (Exact name of registrant as specified in its ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 _____________________________________ MetLife, Inc. (Exact name of registrant as specified in its charter) (State or ...